In The Spotlight
DDNews Cancer Research Exclusive
 
Here's to more survivors
 
(Photo credit: National Cancer Institute)
 
Recent reports from cancer advocacy and research organizations detail an increase in cancer survivors, with incidence and mortality rates dropping in recent years
 
 
NEWS
Magenta Therapeutics presents new research at the Transplant and Cellular Therapy Annual Meeting
 
Agreement focuses on tafasitamab for the treatment of B cell malignancies
 
Shimadzu and Providence Cancer Institute team up to advance cancer immunotherapy research
 
Bio-Rad’s ddPCR technology provides faster, more accurate diagnoses
 
NeoGenomics acquires oncology operation from Human Longevity for $37 million
 
BioNTech announces publication of preclinical data for a CARVac targeting Claudin 6
 
Silverback Therapeutics’ SBT6050 shows promise in HER2-expressing tumors
 
Drug can affect non-Hodgkin’s lymphoma cell lines
 
 
FEATURES
 
 
A look at gastroesophageal, gastric and colorectal cancer progress
 
OPINION
by Martin Lachs/Brandon Fletcher
As excitement and investment related to adoptive cell transfer products increases, there are concerns and issues that need to be addressed in terms of long-term follow-up trials

by Sue Cramp, Charles River
In pursuit of new options for treating childhood cancers, a new approach to drug discovery and development may be an answer

by Andrea Toell of Lonza
Andrea Toell of Lonza shares how CAR T cells are transforming immuno-oncology


 
CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.